NanoPhoria

Milan, Italy

NanoPhoria develops non-viral, nano-delivery systems for cardiovascular treatments, focusing on inhalable biologics.

$97.8M raised

Oct 2025

Series A

Top Investors

CDP Venture CapitalSofinnova PartnersXGEN VenturePanakes PartnersEIC Accelerator

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has NanoPhoria raised?

NanoPhoria has raised $97.8M in total funding. The most recent round was Series A. The last funding was announced in October 2025.

Who are NanoPhoria's investors?

NanoPhoria's investors include CDP Venture Capital, Sofinnova Partners, XGEN Venture, Panakes Partners, EIC Accelerator.

Where is NanoPhoria headquartered?

NanoPhoria is headquartered in Milan, Italy.

What does NanoPhoria do?

NanoPhoria develops non-viral, nano-delivery systems for cardiovascular treatments, focusing on inhalable biologics.

What stage is NanoPhoria at?

NanoPhoria is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 6, 2025.

MLA

"NanoPhoria — Funding & Investors." VCBacked, October 6, 2025, https://www.vcbacked.co/company/nanophoria. Accessed June 3, 2026.

APA

VCBacked. (2025). NanoPhoria — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/nanophoria

Wikipedia (cite web)

{{cite web |title=NanoPhoria — Funding & Investors |url=https://www.vcbacked.co/company/nanophoria |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 6, 2025.